Global Daptomycin Market Outlook 2016-2021

Published: Oct, 2016 | Pages: 99 | Publisher: Gen Consulting Company
Industry: Pharmaceutical | Report Format: Electronic (PDF)

Daptomycin is a lipopeptide antibiotic used in the treatment of systemic and life-threatening infections caused by Gram-positive organisms. It is a naturally occurring compound found in the soil saprotroph Streptomyces roseosporus. Its distinct mechanism of action makes it useful in treating infections caused by multiple drug-resistant bacteria. It is marketed in the United States under the trade name Cubicin by Cubist Pharmaceuticals.

This report provides detailed analysis of worldwide markets for Daptomycin from 2011-2015 and provides extensive market forecasts 2016-2021 by region/country and subsectors. It covers the key technological and market trends in the Daptomycin market and further lays out an analysis of the factors influencing the supply/demand for Daptomycin, and the opportunities/challenges faced by industry participants. It also acts as an essential tool to companies active across the value chain and to the new entrants by enabling them to capitalize the opportunities and develop business strategies.

GCC's report, Global Daptomycin Market Outlook 2016-2021, has been prepared based on the synthesis, analysis, and interpretation of information about the global Daptomycin market collected from specialized sources. The report covers key technological developments in the recent times and profiles leading players in the market and analyzes their key strategies. The competitive landscape section of the report provides a clear insight into the market share analysis of key industry players. The major players in the global Daptomycin market are Merck Sharp & Dohme (Cubist) (USA), OLON S.p.A. (Italy), Zhejiang Hisun (China), Jiangsu Hengrui (China), Huadong Medicine (China), among others.

The report provides separate comprehensive analytics for the North America, Europe, Asia-Pacific, Middle East and Africa and Rest of World. In this sector, global competitive landscape and supply/demand pattern of Daptomycin industry has been provided.

 Table of Contents

Part 1. Scope of Report
1.1 Methodology
1.2 Geographic Scope
1.3 Years Considered

Part 2. Introduction
2.1 Definition
2.2 Current Scenario
2.2 Future Scenario

Part.3 Value Chain Analysis
3.1 Upstream
3.2 Downstream

Part 4. Manufacture
4.1 Manufacturing Process
4.2 Issues and Trends
4.3 Manufacturing Costs

Part 5. Worldwide Key Vendors
5.1 Company A
5.1.1 Business Overview
5.1.2 Products Offered
5.1.3 Business Performance
5.2 Company B
5.3 Company C
5.4 Company D
5.5 Company E
5.6 Company F
5.7 Company G
5.8 Company H
5.9 Company I
5.10 Company J

Part 6. Market Overview
6.1 Global Production Volume 2011-2016
6.2 Production Volume by Region 2011-2016
6.2.1 North America
6.2.2 EMEA
6.2.3 Asia-Pacific
6.2.4 ROW
6.3 Global Production Value 2011-2016
6.4 Production Value by Region
6.4.1 North America
6.4.2 EMEA
6.4.3 Asia-Pacific
6.4.4 ROW

Part 7. Consumption Pattern
7.1 Regional Consumption
7.1.1 North America
7.1.2 EMEA
7.1.3 Asia-Pacific
7.1.4 ROW
7.2 Global Consumption by Application

Part 8. Market Forecast
8.1 Market Size by Volume
8.1.1 North America
8.1.2 EMEA
8.1.3 Asia-Pacific
8.1.4 ROW
8.2 Market Size by Value
8.2.1 North America
8.2.2 EMEA
8.2.3 Asia-Pacific
8.2.4 ROW
8.3 Regional Consumption Forecast
8.3.1 North America
8.3.2 EMEA
8.3.3 Asia-Pacific
8.3.4 ROW
8.4 Consumption Forecast by Application

Part 9. Market Dynamics
9.1 Market Drivers
9.2 Market Constraints
9.3 Market Strategies

Part 10. Key Events
10.1 Mergers & Acquisitions
10.2 New Product Launches
10.3 Expansions
10.4 Other Developments

List of Tables and Figures


Figure Global Daptomycin Production Volume (Unit) 2011-2016
Figure Global Daptomycin Production Value (M USD) 2011-2016
Figure Top 10 Daptomycin Vendors Production Volume Share 2015
Figure Top 10 Daptomycin Vendors Production Value Share 2015
Figure Regional Daptomycin Production (Unit) 2015
Figure Regional Daptomycin Production Value (M USD) 2015
Table Raw Material Materials Suppliers
Figure Global Daptomycin Consumption Pattern 2015
Figure Manufacturing Cost Structure
Figure Company A Daptomycin Products
Table Company A Financial Performance 2011-2016
Figure Company A Market Share 2011-2016
Figure Company B Daptomycin Products
Table Company B Financial Performance 2011-2016
Figure Company B Market Share 2011-2016
Figure Company C Daptomycin Products
Table Company C Financial Performance 2011-2016
Figure Company C Market Share 2011-2016
Figure Company D Daptomycin Products
Table Company D Financial Performance 2011-2016
Figure Company D Market Share 2011-2016
Figure Company E Daptomycin Products
Table Company E Financial Performance 2011-2016
Figure Company E Market Share 2011-2016
Figure Company F Daptomycin Products
Table Company F Financial Performance 2011-2016
Figure Company F Market Share 2011-2016
Figure Company G Daptomycin Products
Table Company G Financial Performance 2011-2016
Figure Company G Market Share 2011-2016
Figure Company H Daptomycin Products
Table Company H Financial Performance 2011-2016
Figure Company H Market Share 2011-2016
Figure Company I Daptomycin Products
Table Company I Financial Performance 2011-2016
Figure Company I Market Share 2011-2016
Figure Company J Daptomycin Products
Table Company J Financial Performance 2011-2016
Figure Company J Market Share 2011-2016
Table Global Key Daptomycin Vendors Production (Unit) 2011-2016
Table Global Key Daptomycin Vendors Production Share 2011-2016
Figure Global Daptomycin Capacity & Production (Unit), Capacity Utilization 2011-2016
Figure Global Top 10 Daptomycin Vendors Production (Unit) 2011-2016
Table Global Top 10 Daptomycin Vendors Production (Unit) 2011
Table Global Top 10 Daptomycin Vendors Production (Unit) 2012
Table Global Top 10 Daptomycin Vendors Production (Unit) 2013
Table Global Top 10 Daptomycin Vendors Production (Unit) 2014
Table Global Top 10 Daptomycin Vendors Production (Unit) 2015
Table Global Top 10 Daptomycin Vendors Production (Unit) 2016
Figure Daptomycin Production Volume (Unit) 2011-2016
Table Global Production Volume (Unit) 2011-2016
Table Global Production Volume Share 2011-2016
Figure North America Daptomycin Capacity & Production (Unit)
Figure North America Production Share Trend
Figure EMEA Daptomycin Capacity & Production (Unit)
Figure EMEA Production Share Trend
Figure Asia-Pacific Daptomycin Capacity & Production (Unit)
Figure Asia-Pacific Production Share Trend
Figure ROW Daptomycin Capacity & Production (Unit)
Figure ROW Production Share Trend Change
Figure Global Daptomycin Production Value (M USD), Growth Rate
Table Global Key Daptomycin Vendors Production Value (M USD) 2011-2016
Table Global Key Daptomycin Vendors Production Value Share 2011-2016
Figure Global Top 10 Daptomycin Vendors Production Value (M USD) 2011-2016
Table Global Top 10 Daptomycin Vendors Production Value (M USD) 2011
Table Global Top 10 Daptomycin Vendors Production Value (M USD) 2012
Table Global Top 10 Daptomycin Vendors Production Value (M USD) 2013
Table Global Top 10 Daptomycin Vendors Production Value (M USD) 2014
Table Global Top 10 Daptomycin Vendors Production Value (M USD) 2015
Table Global Top 10 Daptomycin Vendors Production Value (M USD) 2016
Figure Daptomycin Prices (USD/Ton) 2016
Figure Daptomycin Gross Margin 2016
Figure Daptomycin Production Value (M USD) By Region 2011-2016
Table Global Daptomycin Production Value (M USD) 2011-2016
Table Global Daptomycin Production Value Share 2011-2016
Figure North America Production Value (M USD), Growth Rate
Figure North America Daptomycin Production Value Share Trend
Figure EMEA Production Value (M USD), Growth Rate
Figure EMEA Daptomycin Production Value Share Trend
Figure Asia-Pacific Production Value (M USD), Growth Rate
Figure Asia-Pacific Daptomycin Production Value Share Trend
Figure ROW Production Value (M USD), Growth Rate
Figure ROW Daptomycin Production Value Share Trend
Figure Global Daptomycin Consumption Volume (Unit) 2015
Table Regional Daptomycin Consumption Volume (Unit) 2011-2016
Table Regional Daptomycin Consumption Volume Share 2011-2016
Figure Daptomycin Consumption in North America 2011-2016
Figure Daptomycin Consumption in EMEA 2011-2016
Figure Daptomycin Consumption in Asia-Pacific 2011-2016
Figure Daptomycin Consumption in ROW 2011-2016
Figure Global Daptomycin Consumption Volume (Unit) 2016
Table Global Daptomycin Consumption Volume (Unit) 2011-2016
Table Global Daptomycin Consumption Volume Share 2011-2016
Figure Global Daptomycin Production (Unit) Forecast 2016-2021
Table Global Daptomycin Production (Unit) 2016-2021
Table Global Daptomycin Production Share 2016-2021
Figure North Daptomycin Production (Unit) Forecast 2016-2021
Figure EMEA Daptomycin Production (Unit) Forecast 2016-2021
Figure Asia-Pacific Daptomycin Production (Unit) Forecast 2016-2021
Figure ROW Daptomycin Production (Unit) Forecast 2016-2021
Figure Global Daptomycin Revenue (M USD) Forecast 2016-2021
Table Global Daptomycin Revenue (M USD) 2016-2021
Table Global Daptomycin Revenue Share 2016-2021
Figure North America Daptomycin Revenue (M USD) Forecast 2016-2021
Figure EMEA Daptomycin Revenue (M USD) Forecast 2016-2021
Figure Asia-Pacific Daptomycin Revenue (M USD) Forecast 2016-2021
Figure ROW Daptomycin Revenue (M USD) Forecast 2016-2021
Figure Global Daptomycin Consumption Volume (Unit) 2016-2021
Table Global Daptomycin Consumption Volume (Unit) 2016-2021
Table Global Daptomycin Consumption Volume Share 2016-2021
Figure North America Daptomycin Consumption (Unit) Forecast
Figure EMEA Daptomycin Consumption (Unit) Forecast
Figure Asia-Pacific Daptomycin Consumption (Unit) Forecast
Figure ROW Daptomycin Consumption (Unit) Forecast
Figure Global Daptomycin Consumption Volume (Unit) 2021
Table Global Daptomycin Consumption Volume (Unit) 2016-2021
Table Global Daptomycin Consumption Volume Share 2016-2021
Table Key Strategies for Daptomycin Multinational Corporations
Table Key Strategies for Daptomycin Emerging-Market Players